Excited to announce that PreciGenome will be exhibiting at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in New Orleans, May 13-17, 2025! Join us at Booth #1818 to discover our latest innovations in: Lipid Nanoparticle (LNP) Synthesis Systems: Experience our NanoGenerator™ platform, designed for scalable, reproducible, and cost-effective LNP, liposome, and PLGA nanoparticle production-ideal for applications from early discovery to GMP manufact

StatNano/Grand View Research: A new market report forecasts the global lipid nanoparticle market to reach $1.54 billion by 2030, growing at a CAGR of 13.64%, driven by increased demand for innovative drug delivery solutions. SyVento BioTech: SyVento BioTech participates in the World Vaccine Congress in Washington, D.C., showcasing their expertise in lipid-based nanocarriers and LNP technology for pharmaceutical products including RNA-based drug products. Arbor Biotechno

Arbor Biotechnologies: Unveiled FDA approval of an IND filing for their LNP-mediated treatment for primary hyperoxaluria type 1. Rothwell Figg (Dan Shores): Led a workshop on intellectual property challenges for LNP-based therapies at the LNP Summit. NOF CORPORATION: Presented biodegradable LNPs with tunable immunogenicity for vaccine and gene therapy applications. Serina Therapeutics: Introduced immune-silent POZ-lipid technology as a PEG alternative for LNPs at the

University of Pennsylvania: Developed nitro-oleic acid-modified LNPs for safer plasmid DNA delivery, enabling long-term gene expression in mice. ACS Biochemistry Study: Introduced click chemistry LNPs for targeted mRNA delivery to metabolically labeled cancer cells. Marama Labs: Launched CloudSpec, a tool for rapid lipid nanoparticle analysis, reducing lab times from hours to seconds. Global Market Report: Projected lipid nanoparticle market growth to US$2.39 billion by 20

High-Throughput Screening Applications for Lipid Nanoparticle Development and Optimization

Sanofi: Published research in Nanoscale on optimizing PEGylated lipids for enhanced mRNA delivery efficacy and stability. University of

We are thrilled to announce that PreciGenome will be participating in the American Association for Cancer Research (AACR) Annual Meeting 202

Serina Therapeutics: Presented preclinical data on non-immunogenic POZ-lipid technology at the ACS Spring 2025 Meeting. Genevant Sciences an

This paper falls within the fields of medical mycology, immunology, and vaccinology, specifically addressing the emerging application of mRN

Frontiers in Nanotechnology: Published research article on RNA-lipid nanoparticle therapeutics for women's health, focusing on gynecological

DOTMA vs. DOTAP lipid nanoparticles for GFP expression on human PBMCs and THP-1 cell line Authors:  Erwin Pavel Lamparelli, Elena...

News Summary Nature: Published research on fabrication of mRNA encapsulated lipid nanoparticles using SMART-MaGIC technologies. Clinical P

This paper sits at the intersection of pharmaceutical technology, nanomedicine, and RNA therapeutics – fields that have gained tremendous at

Summary of Recent LNP News Johns Hopkins Institute for NanoBioTechnology: Developed a machine learning model to predict efficient lipid nano

Section 1: Brief Summary of News Nature: Published research on improving safety of lipid nanoparticle-based DNA delivery by incorporating

1. Arbutus Biopharma Appoints New CEO and Restructures Board to Prioritize LNP Technology Release Date : February 25, 2025 Source :...

Introduction Poly(lactic co-glycolic acid) (PLGA) is a synthetic biodegradable polymer commonly used in drug delivery applications...

Microfluidic Monodispersed Microbubble Generation Droplet

Authors: César Palacios-Arias, Marc Jofre, María-José López, Youness Akazzim, Lluis Jofre, Jordi Romeu, and Luis Jofre-Roca César...